COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care

Primary Care Respiratory Journal

Volumn 15, Issue 2, 2006, Pages 84-91

  Steuten, Lotte M G ^a   Creutzberg, Eva C ^b,c,d   Vrijhoef, Hubertus J M ^a,d   Wouters, Emiel F ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Center for Integrated Rehabilitation of Organ Failure   (Netherlands)

^c Clinical Research Unit   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BMI; Dyspnoea; FFM depletion; GOLD stages; Primary care

Indexed keywords

FAT;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; UNDERWEIGHT;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; NUTRITIONAL STATUS; OBESITY; PREVALENCE; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; THINNESS;

EID: 33645118802     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.1016/j.pcrj.2005.09.001     Document Type: Article

References (46)

1. R.A. Pauwels, S. Buist, P.M.A. Calverly, C.R. Jenkins, and S.S. Hurd Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary Am J Respir Crit Care Med 163 2001 1256 1276
2. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study The Lancet 349 1997 1436 1442
3. E.F. Wouters Economic analysis of the Confronting COPD survey: an overview of results Respir Med 97 2003 S3 S14
4. M. Ferrer, J. Alonso, and J. Morera Chronic obstructive pulmonary disease stage and health-related quality of life Ann Int Med 127 1997 1072 1079
5. M. Friedman, C. Serby, S. Menjoge, J. Wilson, D. Hileman, and T. Witek Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD Chest 115 1999 635 641
6. P.S. Burge, P.M. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, and T.K. Maslen Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 320 2000 1297 1303
7. B.R. Celli, C.G. Cote, and J.M. Marin The body-mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease NEJM 350 10 2004 1005 1012
8. Nocturnal Oxygen Therapy Trial Group Continuous or nocturnal therapy in hypoxemic chronic obstructive pulmonary disease: a clinical trial Ann Intern Med 93 1980 391 398
9. The Intermittent Positive Pressure Breathing Trial Group Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease: a clinical trial Ann Intern Med 99 1983 612 620
10. D.A. Gerardi, L. Lovett, M.L. Benoit-Connors, J.Z. Reardon, and R.L. ZuWallack Variables related to increased mortality following outpatient pulmonary rehabilitation Eur Respir J 9 1996 431 435
11. K. Nishimura, T. Izumi, M. Tsukino, and T. Oga Dyspnoea is a better predictor of 5-year survival than airway obstruction in patients with COPD Chest 121 2002 1434 1440
12. A.M. Schols, J. Slangen, L. Volovics, and E.F. Wouters Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1791 1797
13. C. Landbo, E. Prescott, P. Lange, J. Vestbo, and T.P. Almdal Prognostic value of nutritional status in chronic obstructive pulmonary disease Am J Respir Crit Care Med 160 1999 1856 1861
14. A.M.W.J. Schols, R. Broekhuizen, C.A. Weling-Scheepers, and E.F.M. Wouters Body composition and mortality in chronic obstructive pulmonary disease Am J Clin Nutr 82 2005 53 59
15. E.F. Wouters, E.C. Creutzberg, and A.M. Schols Systemic effects in COPD Chest 121 2002 127S 130S
16. E.M. Baarends, A.M. Schols, R. Mostert, and E.F. Wouters Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease Eur Respir J 10 1997 2807 2813
17. P. Palange, S. Forte, A. Felli, P. Galassetti, P. Serra, and S. Carlone Nutritional state and exercise tolerance in patients with COPD Chest 107 1995 1206 1212
18. M.P. Engelen, A.M. Schols, J.D. Does, and E.F. Wouters Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease Am J Clin Nutr 71 2000 733 738
19. P. Palange, S. Forte, and P. Onorati Effect of reduced body weight on muscle aerobic capacity in patients with COPD Chest 114 1998 12 18
20. R. Mostert, A. Goris, C. Weling-Scheepers, E.F. Wouters, and A.M. Schols Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease Respir Med 94 2000 859 867
21. A.M. Schols Nutrition in chronic obstructive pulmonary disease Curr Opin Pulm Med 6 2000 110 115
22. Y.N. Berner The contribution of obesity to dyspnoea in elderly people Age Ageing 30 6 2001 530
23. S.F. Ho, M.S. O'Mahony, J.A. Steward, P. Breay, M. Buchalter, and M.L. Burr Dyspnoea and quality of life in older people at home Age and Ageing 30 2001 155 159
24. Definitions, epidemiology, pathophysiology, diagnosis, and staging Am J Resp Crit Care Med 152 Suppl 1995 S78 S83
25. J.C. Bestall, E.A. Paul, R. Garrod, R. Garnham, P.W. Jones, and J.A. Wedzicha Usefulness of the MRC dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease Thorax 54 1999 581 586
26. D.A. Mahler, D.H. Einberg, C.K. Wells, and A.R. Feinstein The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest 85 1984 751 758
27. T. Hajiro, K. Nishimura, M. Tsukino, A. Ikeda, H. Koyama, and T. Izumi Comparison of discriminative properties among disease-specific questionnaires for measuring health related quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 785 790
28. M. Hoogendoorn, M.P.M.H. Rutten-van Mölken, and R.T. Hoogenveen A dynamic population model of disease progression in COPD Eur Respir J 26 2005 223 233
29. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows. Report Working party Standardization of Lung Function Tests, European Community for Steel and Coal; Official Statement for the European Respiratory Society Eur Respir J 6 1993 5 40
30. E.C. Creutzberg, E.F. Wouters, R. Mostert, C.A. Weling-Scheepers, and A.M. Schols Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease Nutrition 19 2003 120 127
31. T.L. Feenstra, M.L.L. Van Genugten, R.T. Hoogenveen, E.F. Wouters, and M.P.M.H. Rutten-van Mölken The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 590 596
32. A.B. Varkey Chronic obstructive pulmonary disease in women: exploring gender differences Curr Opin Pulm Med 10 2004 98 103
33. N. Le Moual, S.M. Kennedy, and F. Kauffman Occupational exposures and asthma in 14,000 adults from the general population Am J Epidemiol 160 2004 1108 1116
34. F.M.E. Franssen, R. Broekhuizen, P.P. Janssen, E.F.M. Wouters, and A.M.W.J. Schols Effects of whole-body exercise training on body composition and functional capacity in normal-weight patienst with COPD Chest 125 2004 2021 2028
35. N.R. Anthonisen Smoking, lung function, and mortality Thorax 55 2000 729 734
36. E.J. Wagena, M.J. Huibers, and C.P. Van Schaijk Therapies for smoking cessation (antidepressants, nicotine replacement and counselling) and implications for the treatment of patients with chronic obstructive pulmonary disease Ned Tijdsch Geneeskd 145 31 2001 1492 1496 (in Dutch)
37. H. Sahebjami, and E. Sathianpitayakul Influence of body weight in emphysema Am J Respir Crit Care Med 161 2000 886 890
38. R. Shoup, G. Dalsky, and S. Warner Body composition and health-related quality of life in patients with obstructive airways disease Eur Respir J 10 1997 1576 1580
39. K. Marquis, R. Debigaré, and Y. Lacasse Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 2002 809 813
40. J. Efthimiou, J. Fleming, C. Gomez, and S.G. Spiro The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease Am Rev Respir Dis 137 1988 1075 1082
41. J.S. Whittaker, C.F. Ryan, P.A. Buckley, and J.D. Road The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients Am Rev Respir Dis 142 1990 283 288
42. R.M. Rogers, M. Donahoe, and J. Costantino Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease Am Rev Respir Dis 146 1992 1511 1517
43. A.M.W.J. Schols, P.B. Soeters, R.M. Mostert, R.J. Pluymers, P.J. Frantzen, and E.F.M. Wouters Physiological effects of nutritional support and anabolic steroids in COPD patients Am J Respir Crit Care Med 152 1995 1268 1274
44. C.H.E. Fuenzalida, T.L. Petty, P.L.M. Jones, and H.M. Hambridge The immune response to short-term nutritional intervention in advanced chronic obstructive pulmonary disease Am Rev Respir Dis 142 1990 49 56
45. I.M.B. Ferreira, D. Brooks, Y. Lacasse, and R.S. Goldstein Nutritional support for individuals with COPD: a meta-analysis Chest 117 2000 672 678
46. M. Decramer, R. Gosselink, T. Troosters, M. Verschueren, and G. Evers Muscle weakness is related to utilization of health care resources in COPD patients Eur Respir J 10 1997 417 423